Cargando…

Imaging of metastatic melanoma

Cutaneous cancer is now the most common human malignancy and in the UK malignant melanoma comprises 11% of all skin cancers. Eighty percent of malignant melanoma is thought to be related to excessive exposure to sunlight, particularly in childhood. Although the least common skin cancer, malignant me...

Descripción completa

Detalles Bibliográficos
Autor principal: Michael King, D
Formato: Texto
Lenguaje:English
Publicado: e-MED 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766563/
https://www.ncbi.nlm.nih.gov/pubmed/17208677
http://dx.doi.org/10.1102/1470-7330.2006.0033
_version_ 1782131668842184704
author Michael King, D
author_facet Michael King, D
author_sort Michael King, D
collection PubMed
description Cutaneous cancer is now the most common human malignancy and in the UK malignant melanoma comprises 11% of all skin cancers. Eighty percent of malignant melanoma is thought to be related to excessive exposure to sunlight, particularly in childhood. Although the least common skin cancer, malignant melanoma is the most deadly. In 1999 it killed over 1600 individuals in the UK and by 2004, in the USA, 55,100 new cases were anticipated. The incidence of this disease is increasing more rapidly than any other malignancy and in males there was a four-fold increase in incidence between 1971 and 1997 whilst there was a three-fold increase in women. Cutaneous melanoma is arguably the most widely metastasising neoplastic disease and it has a particularly unpredictable pattern of spread. Imaging has an important role in the management of this disease as the demonstration and delineation of metastases influences management and prognosis.
format Text
id pubmed-1766563
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher e-MED
record_format MEDLINE/PubMed
spelling pubmed-17665632008-12-22 Imaging of metastatic melanoma Michael King, D Cancer Imaging Article Cutaneous cancer is now the most common human malignancy and in the UK malignant melanoma comprises 11% of all skin cancers. Eighty percent of malignant melanoma is thought to be related to excessive exposure to sunlight, particularly in childhood. Although the least common skin cancer, malignant melanoma is the most deadly. In 1999 it killed over 1600 individuals in the UK and by 2004, in the USA, 55,100 new cases were anticipated. The incidence of this disease is increasing more rapidly than any other malignancy and in males there was a four-fold increase in incidence between 1971 and 1997 whilst there was a three-fold increase in women. Cutaneous melanoma is arguably the most widely metastasising neoplastic disease and it has a particularly unpredictable pattern of spread. Imaging has an important role in the management of this disease as the demonstration and delineation of metastases influences management and prognosis. e-MED 2006-12-22 /pmc/articles/PMC1766563/ /pubmed/17208677 http://dx.doi.org/10.1102/1470-7330.2006.0033 Text en Copyright © 2006 International Cancer Imaging Society
spellingShingle Article
Michael King, D
Imaging of metastatic melanoma
title Imaging of metastatic melanoma
title_full Imaging of metastatic melanoma
title_fullStr Imaging of metastatic melanoma
title_full_unstemmed Imaging of metastatic melanoma
title_short Imaging of metastatic melanoma
title_sort imaging of metastatic melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766563/
https://www.ncbi.nlm.nih.gov/pubmed/17208677
http://dx.doi.org/10.1102/1470-7330.2006.0033
work_keys_str_mv AT michaelkingd imagingofmetastaticmelanoma